Literature DB >> 23327523

Reprogrammed cells for disease modeling and regenerative medicine.

Anne B C Cherry1, George Q Daley.   

Abstract

The conversion of somatic cells into pluripotent cells is transforming the way diseases are researched and treated. Induced pluripotent stem (iPS) cells' promise may soon be realized in the field of hematology, as hematopoietic stem cell transplants are already commonplace in clinics around the world. We provide a current comparison between induced pluripotent and embryonic stem cells, describe progress toward modeling hematological disorders using iPS cells, and illustrate the hurdles that must be overcome before iPS cell therapies will be available in clinics.

Entities:  

Mesh：

Year:  2013        PMID： 23327523      PMCID： PMC3629705          DOI： 10.1146/annurev-med-050311-163324

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN： 0066-4219            Impact factor:   13.739


  69 in total

Review 1.  Hematopoietic stem-cell transplantation.

Authors:  Edward A Copelan
Journal:  N Engl J Med       Date:  2006-04-27       Impact factor: 91.245

2.  Marked differences in differentiation propensity among human embryonic stem cell lines.

Authors:  Kenji Osafune; Leslie Caron; Malgorzata Borowiak; Rita J Martinez; Claire S Fitz-Gerald; Yasunori Sato; Chad A Cowan; Kenneth R Chien; Douglas A Melton
Journal:  Nat Biotechnol       Date:  2008-02-17       Impact factor: 54.908

Review 3.  Bone-marrow transplantation (first of two parts).

Authors:  E Thomas; R Storb; R A Clift; A Fefer; F L Johnson; P E Neiman; K G Lerner; H Glucksberg; C D Buckner
Journal:  N Engl J Med       Date:  1975-04-17       Impact factor: 91.245

4.  Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease.

Authors:  Jizhong Zou; Prashant Mali; Xiaosong Huang; Sarah N Dowey; Linzhao Cheng
Journal:  Blood       Date:  2011-08-31       Impact factor: 22.113

5.  Blood stem cells emerge from aortic endothelium by a novel type of cell transition.

Authors:  Karima Kissa; Philippe Herbomel
Journal:  Nature       Date:  2010-02-14       Impact factor: 49.962

6.  A more efficient method to generate integration-free human iPS cells.

Authors:  Keisuke Okita; Yasuko Matsumura; Yoshiko Sato; Aki Okada; Asuka Morizane; Satoshi Okamoto; Hyenjong Hong; Masato Nakagawa; Koji Tanabe; Ken-ichi Tezuka; Toshiyuki Shibata; Takahiro Kunisada; Masayo Takahashi; Jun Takahashi; Hiroh Saji; Shinya Yamanaka
Journal:  Nat Methods       Date:  2011-04-03       Impact factor: 28.547

7.  HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors.

Authors:  Michael Kyba; Rita C R Perlingeiro; George Q Daley
Journal:  Cell       Date:  2002-04-05       Impact factor: 41.582

8.  Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures.

Authors:  Mark H Chin; Mike J Mason; Wei Xie; Stefano Volinia; Mike Singer; Cory Peterson; Gayane Ambartsumyan; Otaren Aimiuwu; Laura Richter; Jin Zhang; Ivan Khvorostov; Vanessa Ott; Michael Grunstein; Neta Lavon; Nissim Benvenisty; Carlo M Croce; Amander T Clark; Tim Baxter; April D Pyle; Mike A Teitell; Matteo Pelegrini; Kathrin Plath; William E Lowry
Journal:  Cell Stem Cell       Date:  2009-07-02       Impact factor: 24.633

9.  Sheep cloned by nuclear transfer from a cultured cell line.

Authors:  K H Campbell; J McWhir; W A Ritchie; I Wilmut
Journal:  Nature       Date:  1996-03-07       Impact factor: 49.962

10.  Hematopoietic stem cell transplantation for severe aplastic anemia--experience of an institute in Taiwan.

Authors:  L Y Bai; T J Chiou; J H Liu; C C Yen; W S Wang; M H Yan; L T Hsiao; T C Chao; P M Chen
Journal:  Ann Hematol       Date:  2003-10-03       Impact factor: 3.673
View more
  69 in total

Review 1.  Application of cell and biomaterial-based tissue engineering methods in the treatment of cartilage, menisci and ligament injuries.

Authors:  Tomasz Trzeciak; Magdalena Richter; Wiktoria Suchorska; Ewelina Augustyniak; Michał Lach; Małgorzata Kaczmarek; Jacek Kaczmarczyk
Journal:  Int Orthop       Date:  2016-01-14       Impact factor: 3.075

2.  The future of iPS cells in advancing regenerative medicine.

Authors:  Peng Liu; K E Li; Shaohua Xu
Journal:  Genet Res (Camb)       Date:  2016-02-11       Impact factor: 1.588

3.  Generation and homing of iPSC-derived hematopoietic cells in vivo.

Authors:  Bin-Kuan Chou; Zhaohui Ye; Linzhao Cheng
Journal:  Mol Ther       Date:  2013-07       Impact factor: 11.454

Review 4.  Toward pluripotency by reprogramming: mechanisms and application.

Authors:  Tao Wang; Stephen T Warren; Peng Jin
Journal:  Protein Cell       Date:  2013-11       Impact factor: 14.870

Review 5.  Transcription factor-mediated reprogramming toward hematopoietic stem cells.

Authors:  Wataru Ebina; Derrick J Rossi
Journal:  EMBO J       Date:  2015-02-20       Impact factor: 11.598

6.  Gaucher Disease-Induced Pluripotent Stem Cells Display Decreased Erythroid Potential and Aberrant Myelopoiesis.

Authors:  Judi A Sgambato; Tea Soon Park; Diana Miller; Leelamma M Panicker; Ellen Sidransky; Yu Lun; Ola Awad; Søren M Bentzen; Elias T Zambidis; Ricardo A Feldman
Journal:  Stem Cells Transl Med       Date:  2015-06-10       Impact factor: 6.940

Review 7.  De novo generation of HSCs from somatic and pluripotent stem cell sources.

Authors:  Linda T Vo; George Q Daley
Journal:  Blood       Date:  2015-03-11       Impact factor: 22.113

Review 8.  Glycosylation and stem cells: Regulatory roles and application of iPSCs in the study of glycosylation-related disorders.

Authors:  Ryan P Berger; Michelle Dookwah; Richard Steet; Stephen Dalton
Journal:  Bioessays       Date:  2016-09-26       Impact factor: 4.345

9.  Induced pluripotent stem cell reprogramming by integration-free Sendai virus vectors from peripheral blood of patients with craniometaphyseal dysplasia.

Authors:  I-Ping Chen; Keiichi Fukuda; Noemi Fusaki; Akihiro Iida; Mamoru Hasegawa; Alexander Lichtler; Ernst J Reichenberger
Journal:  Cell Reprogram       Date:  2013-11-12       Impact factor: 1.987

10.  Gaucher iPSC-derived macrophages produce elevated levels of inflammatory mediators and serve as a new platform for therapeutic development.

Authors:  Leelamma M Panicker; Diana Miller; Ola Awad; Vivek Bose; Yu Lun; Tea Soon Park; Elias T Zambidis; Judi A Sgambato; Ricardo A Feldman
Journal:  Stem Cells       Date:  2014-09       Impact factor: 6.277
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.